Can the inevitable be prevented? : an analysis of loss to follow-up among grown-ups with congenital heart disease in Malta by Caruana, Maryanne et al.
Editorial OrgOdRe Original Article 
 Malta Medical Journal     Volume 30  Issue 01 2018 
Abstract 
Aims: To investigate the prevalence of loss to 
follow-up, factors predisposing to loss to follow-up 
and the outcome of recall into specialist care among 
grown-ups with congenital heart disease (GUCH) of 
moderate or severe complexity prior to the 
introduction of formal transition in Malta.  
Methods: Medical documentation for all live 
patients with tetralogy of Fallot, aortic 
coarctation/interrupted aortic arch, partial and 
complete atrioventricular septal defect, Fontan-type 
circulation and transposition of the great arteries in 
our institutional database aged ≥16 years was 
analysed to determine follow-up status.  Patients 
lost to follow-up were recalled through a postal 
appointment.  Ordinal logistic regression was used 
to analyse the effect of gender, CHD complexity, 
consistency of paediatric cardiology follow-up 
during childhood, number of cardiac 
surgical/interventional procedures and use of long-
term cardiac medications on loss to follow-up. 
Results: Forty-one of 187 patients (21.9%) (27 
males; 34 with moderate disease) had been lost to 
follow-up.  Limited paediatric cardiology input 
(OR, 5.08; 95% CI, 1.77-14.63) (p=0.003), 1 
surgical/interventional procedures (OR, 3.34; 95% 
CI, 1.09-10.26) (p=0.035) and no long-term cardiac 
medications (OR 7.34; 95% CI, 1.74-31.02) 
(p=0.007) were associated with higher risk of loss 
to follow-up.  A positive response to recall was 
obtained from 33/41 (80.5%) patients.  Significant 
cardiac morbidity was found in 5/33 (15.2%) 
patients upon reassessment. 
Conclusions: Loss to specialist follow-up 
occurs even in health systems with little perceived 
barriers to medical care.  Consistent specialist input 
during all stages and patient and family education 
through formal transition can help ensure a 
smoother transfer to GUCH care. 
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Introduction 
Major advances in cardiac surgery and 
transcatheter interventions have made it possible for 
most children born with congenital heart disease 
(CHD) to survive into adulthood.1-3  However, 
complete cure is seldom achieved and lifelong 
specialist follow-up is required to allow early 
detection and timely management of significant 
recurrent or residual structural lesions and 
arrhythmias as these patients grow older.4  Several 
lesion-specific guidelines containing indications on 
the nature and frequency of long-term follow-up for 
these patients have been published.5-7  Lapses of 
care resulting from loss to follow-up represent a 
major set-back in this surveillance process and can 
have a negative impact on long-term outcomes.8-9  
The incidence of CHD in Malta is 8/1000 live 
births, which is similar to that in other European 
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countries.10 Transfer of care from paediatric to adult 
services across all specialties takes place at the age 
of 14-16 years.  Virtually all congenital cardiac 
surgery on children and adults is carried out in 
overseas tertiary referral centres, in the United 
Kingdom, through a bilateral national health service 
agreement, while a number of structural cardiac 
interventions are carried out locally by visiting 
specialists. A structured paediatric cardiology 
service started operating in the main teaching 
hospital in the early 1990s.  A Grown-Up 
Congenital Heart disease service was set up a few 
years later, while a formal transition process was 
instituted at the end of 2015.  Up to the time of 
writing, there was no clinical nurse specialist cover 
for paediatric cardiology, transition or GUCH 
clinics.11 
The aims of this study were (a) to determine the 
prevalence of loss to GUCH follow-up (b) to 
investigate potential factors predisposing to loss to 
follow-up and (c) to analyse the outcome of an 
exercise in recall into GUCH care in a cohort of 
Maltese adult patients with CHD of moderate or 
severe complexity in the period preceding the 
introduction of a formal transition process.  
Methods 
(a) Study cohort and prevalence of loss to GUCH
follow-up
Five specific congenital cardiac lesions of
moderate or severe complexity – (i) tetralogy of 
Fallot (TOF), (ii) aortic coarctation and interrupted 
aortic arch (CoA/IAA), (iii) partial and complete 
atrioventricular septal defects (AVSD), (iv) 
univentricular physiology with Fontan-type 
palliation (UVH-Fontan), (v) transposition of the 
great arteries (TGA) with arterial or atrial switch 
repair - were chosen arbitrarily for inclusion in this 
study, based on the well-established notion that all 
these lesions warrant regular long-term specialist 
follow-up.5-7  A query for each of these lesions as 
the primary diagnosis was run in our institutional 
congenital cardiac database (MAPCAD)3,12 at the 
end of 2013, among Maltese subjects born before 
end December 1997 (and thus aged 16 years or over 
by time of data extraction).  Following this initial 
query, only live subjects whose complete medical 
documentation could be traced were subsequently 
included.  Non-Maltese nationals that might have 
entered the congenital cardiac system upon 
relocating to the islands were purposefully excluded 
to avoid the potential bias introduced by differences 
in access to medical care.  The study protocol was 
approved by the University of Malta Research 
Ethics Committee and conforms to the ethical 
guidelines of the 1975 Declaration of Helsinki. 
Clinical details and follow-up records were 
obtained from hospital paper notes and digital 
appointment systems in use at our institution.  Loss 
to GUCH follow-up was defined as lack of written 
or digital documentation attesting to ongoing 
clinical encounters within the GUCH service as of 
the age of 16 years. 
(b) Investigation of potential factors predisposing
to loss to GUCH follow-up
The potential impact of five factors – (a) patient
gender (b) CHD complexity (c) paediatric 
cardiology follow-up during childhood (d) number 
of cardiac surgical/interventional procedures (e) use 
of long-term cardiac medications – on loss to 
GUCH follow-up were investigated.  CHD 
complexity was classified in line with the 
recommendations of Task Force 1 of the 32nd 
Bethesda Conference.4  The term “paediatric 
cardiology follow-up during childhood” referred to 
significant input by a local or visiting paediatric 
cardiologist in the management of CHD up to the 
age of transfer to adult care, and was classified as 
‘limited’ or ‘regular’.  “Surgical/interventional 
procedures” refers to any open surgical procedure 
or transcatheter intervention undertaken to repair or 
relieve the original congenital defect and any 
important residual or recurrent lesions related to it 
but excluded diagnostic cardiac catheter studies.  
This term also included electrophysiological 
procedures and the implantation of a permanent 
pacemaker or implantable cardioverter-defibrillator 
for the management of significant arrhythmias.  
“Long-term cardiac medications” refers to any 
medications being used for the management of 
ventricular systolic and/or diastolic dysfunction, 
antiarrhythmic drugs, antiplatelet and anticoagulant 
agents and antihypertensive medications. 
(c) Analysis of exercise of recall into GUCH care
All subjects that had been lost to follow-up
were recalled to GUCH clinic through a postal 
appointment as per our institution’s outpatient 
policy, with a second appointment given in case of 
a negative initial response.  The responses to recall 
and cardiac morbidity at time of reassessment were 
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obtained from the hospital digital patient 
management systems and medical notes.  The term 
“reassessment” refers to the GUCH clinic visit and 
subsequent imaging, functional testing and 
arrhythmia assessment triggered by the cardiologist.  
“Significant cardiac morbidity” at time of 
reassessment refers to a significant structural lesion, 
impairment of functional status or arrhythmias 
requiring a prompt surgical, percutaneous or 
electrophysiological intervention or change in 
medical management.  
(d) Statistical methods
Descriptive statistics included proportions for
categorical variables and mean  1 standard 
deviation for continuous variables.  Ordinal logistic 
regression was used to generate odds ratios (OR) 
for loss to GUCH follow-up based on patient 
gender (male vs. female), moderate vs. severe 
lesion complexity, limited vs. regular paediatric 
cardiology follow-up, 1 vs. >1 
surgical/interventional procedure and no vs. on 
long-term cardiac medications.  All analyses were 
performed using SPSS 21 (IBM® SPSS® 21, SPSS 
Inc., Chicago IL, USA).  Statistical significance 
was defined as p<0.05. 
Results 
(a) Study cohort characteristics and prevalence of
loss to follow-up
The initial database query returned 211 subjects
with one of the above congenital cardiac lesions 
aged ≥16 years.  Twenty-four subjects could not be 
traced or had died before the time of data extraction 
and were excluded.  The study cohort consisted of 
187 patients as follows: TOF = 70, CoA/IAA = 56, 
AVSD = 34, UVH-Fontan = 13, TGA = 14 (Figure 
1).  The main characteristics of these patients are 
summarised in Table 1.  Forty-one of 187 patients 
(21.9%) (27 males; 34 moderate CHD) had been 
lost to GUCH follow-up: TOF = 10/70 (14.3%), 
CoA/IAA = 22/56 (39.3%), AVSD = 4/34 (11.8%), 
UVH-Fontan palliation = 1/13 (7.7%), TGA = 4/14 
(26.7%). 
(b) Factors predisposing to loss to GUCH
follow-up
Ordinal logistic regression analysis identified
the following factors to be associated with a 
significantly higher risk of loss to GUCH follow-
up: limited paediatric cardiology follow-up (OR, 
5.08; 95% CI, 1.77-14.63), 1 
surgical/interventional procedure (OR, 3.34; 95% 
CI, 1.09-10.26) and no long-term cardiac 
medications (OR 7.34; 95% CI, 1.74-31.02).  
Patient gender and lesion complexity (moderate 
compared to severe complexity) had no statistically 
significant impact on loss to follow-up (Table 2). 
(c) Analysis of recall into GUCH care
The mean age at time of recall for the 41
patients that were lost to GUCH follow-up was 
34.73  13.88 years.  A positive response was 
obtained from 33/41 (80.5%) patients (21 males; 
moderate CHD = 28/34, severe CHD = 5/7).  
Significant cardiac morbidity was found in 5/33 
(15.2%) patients upon reassessment in the GUCH 
service (Figure 2).  Two patients with previous 
transannular patch TOF repair needed surgical 
pulmonary valve replacement (PVR) for severe 
pulmonary regurgitation (PR) and one patient with 
TOF and previous palliative open pulmonary 
valvotomy was offered balloon pulmonary 
valvuloplasty for severe recurrent valvular 
pulmonary stenosis (PS).  One patient with 
unrepaired partial AVSD and severe left 
atrioventricular valve (LAVV) regurgitation 
underwent surgical defect closure and LAVV repair 
and one patient with Eisenmenger AVSD required 
optimisation of pulmonary vasodilator treatment.  
Table 1: Characteristics of the 187 patients included in the study 
Characteristic No. of patients (n (%)) 
Male gender 107 (57.2) 
Moderate complexity 145 (77.5) 
1 surgical/interventional procedure 111 (59.4) 
No cardiac medications 103 (65.2) 
Limited paediatric cardiology follow-up 60 (32.1) 
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Figure 1: Generation of study cohort.  The term “missing” refers to subjects logged in the institutional 
congenital cardiac database (MAPCAD) that either died before the end of 2013 (time of data extraction) or who 
could not be traced on the institutional data information system. (AVSD = atrioventricular septal defect; CoA = 
coarctation of the aorta; IAA = interrupted aortic arch; TGA = transposition of great arteries; TOF = tetralogy 
of Fallot; UVH = univentricular heart) 
Table 2: Outcome of ordinal logistic regression analysis of the impact of five studied factors on likelihood of 
loss to ACHD follow-up 
* Significant p values are shown in bold
Factor OR 95% CI 
lower, upper 
p 
value* 
Male vs. female gender 2.12 0.80, 5.65 0.132 
Moderate vs. great complexity 1.60 0.32, 8.03 0.569 
Limited vs. regular paediatric cardiology follow-up 5.08 1.77, 14.63 0.003 
1 vs.  >1 cardiac surgery/intervention 3.34 1.09, 10.26 0.035 
No vs. on long-term cardiac medication 7.34 1.74, 31.02 0.007 
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Figure 2: Outcomes of recall exercise for the 41 patients lost to GUCH follow-up.   Thirty-three of the recalled 
subjects attended an appointment in GUCH clinic, and 5/33 needed management of significant cardiac 
morbidity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Nowadays, loss to specialist follow-up is 
recognised as an important stumbling block to the 
effective management of GUCH patients 
worldwide.8-9,13-18  Ours is the first study to 
investigate this phenomenon among adult patients 
with CHD of moderate and severe complexity in the 
Maltese population. 
 
(a)  Prevalence of loss to follow-up and 
associated factors 
The prevalence of loss to follow-up in our 
study cohort was 21.9%.  There are wide variations 
in loss to follow-up rates in the published literature 
and ours appears to be one of the lowest reported.  
In their 2009 study on 643 subjects with CHD of all 
complexities in Quebec, Canada, Mackie et al 14 
found that 61% of CHD patients were not being 
seen by a cardiologist by the age of 22 years, while 
the 2013 multi-centre North American study by 
Gurvitz et al 19 reported that 42% of the 922 
patients with CHD of all complexities aged ≥18 
years and attending their GUCH centre visit 
admitted to at least one >3-year gap in cardiology 
care.  From their single-centre experience in 
Leuven, Belgium, Moons et al 18 reported that 54% 
of all CHD patients were not under active clinical 
follow-up.  Yeung et al found a >2-year lapse in 
cardiology care in 63% of 158 patients with 
moderate/severe CHD in a centre in Colorado, US, 
and Reid et al 13 reported a rate of failure to transfer 
to GUCH care of 53% among 360 patients with 
complex CHD in Toronto, Canada.  Wray et al 20 
carried out a similar exercise to ours concentrating 
on repaired TOF in one main tertiary centre in the 
United Kingdom (UK) and found a 24% loss to 
follow-up rate.  De Bono et al 21 documented a 
nearly 50% rate of loss to follow-up among patients 
with repaired aortic coarctation referred to a UK 
regional GUCH centre.  It is likely that the small 
geographical area of the Maltese islands, the 
universal access to medical care and the 
concentration of specialist care in one main centre 
together contribute significantly to the relatively 
low rate of loss to follow-up documented in our 
study.  All the other studies referred to earlier were 
conducted in countries far larger than Malta, and 
often where GUCH care is provided in multiple 
centres possibly different to those delivering 
paediatric care.  At the same time, the fact that over 
one fifth of patients with moderate or severe CHD 
in our study were lost to follow-up despite this 
combination of favourable circumstances highlights 
the relative ease with which these patients can “slip 
through the net” and underlines the importance of 
implementing a robust infrastructure to ensure their 
17
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safe transfer from paediatric to adult care. 
As expected, a lower number of cardiac 
interventional or surgical procedures was associated 
with a higher risk of loss to adult specialist 
cardiology follow-up in our study population.  
Similar findings were documented by Mackie et al 
14 and Reid et al 13, in whose studies a higher 
number of cardiac procedures was associated with a 
better chance to transfer to adult care.  In another 
study by Mackie and colleagues 15, cardiac 
catheterisation in the preceding 5 years was also 
found to be associated with a lower likelihood of 
loss to follow-up.  It is likely that a higher number 
of cardiac procedures, especially if undertaken in 
older years, acts as a “reminder” to patients and 
family of their cardiac condition.  In addition to 
this, a higher number of cardiac procedures leads to 
more encounters with specialists that are more 
likely to reiterate the importance of long-term 
follow-up and ensure its implementation.  We found 
that the lack of regular cardiac medications was also 
associated with a higher risk of loss to follow-up.  
To our knowledge, ours is the first study to 
investigate the association between cardiac 
medication use and loss to GUCH follow-up.  It can 
be postulated that the need for daily medications 
acts as another “reminder” to patients of a chronic 
condition that warrants specialist follow-up.  
Furthermore, the need to have prescriptions written 
from time to time, ensures patients’ contact with 
medical professionals who can in turn ensure that 
such follow-up is in place. 
The other factor with a significant association 
with loss to follow-up in our study cohort was a 
limited paediatric cardiology follow-up when 
compared to a more consistent input.  Findings in 
several other studies reinforce our observation.  In 
analysing the timing of loss to follow-up in their 
population, Mackie et al demonstrated that the 
greatest loss to follow-up happened during 
childhood and prior to the time of transfer to adult 
care.14  Others showed that clear documentation in 
medical notes about the need for follow-up in a 
GUCH centre and recommendations on follow-up 
timeframes correlated with more successful transfer 
to adult care.13,15  A number of interview-based 
studies featured the impression of the congenital 
defect being treated or of not knowing about the 
need for follow-up 8,15,19-20 as leading patient-
reported responses for gaps in cardiology care.  
With their better understanding of the sequelae of 
repaired and unrepaired CHD, it would be 
reasonable to expect paediatric cardiologists to 
better convey the idea of need for long-term follow-
up both in their written treatment plans and in their 
communication with patient and family from an 
early stage, thus ensuring better transfer to adult 
care.   
We found no association between lesion 
complexity (moderate vs. severe) and likelihood of 
loss to GUCH follow-up.  This contrasts with the 
findings by Yeung et al 8, who also restricted their 
study to patients with lesions of moderate or severe 
complexity and found those with moderate disease 
to have a significantly higher likelihood of >2-year 
gaps in cardiology care.   Other studies that 
included patients with CHD of all complexities 14,19, 
found those with mild disease to be at highest risk 
of loss to follow-up or to experience gaps in care.  
Males often show an increased prevalence of risk-
taking behaviour, and some authors found male 
gender to be associated with loss to follow-up 
before adulthood.14 Although a previous study 
among Maltese GUCH patients had confirmed more 
risk-taking behaviours in male patients with respect 
to some lifestyle habits 11, our current study failed 
to show a significant association between gender 
and loss to follow-up. 
(b) Recall of GUCH patients lost to follow-up
To our knowledge, there are only two other
nationwide exercises aimed at recalling GUCH 
patients lost to follow-up reported in the literature 
to date: a Danish television and newspaper 
campaign in 2005 16 and a national media campaign 
organised by the CONCOR project group in the 
Netherlands in 2009.22  The exercise carried out in 
the Netherlands helped identify 593 patients aged 
20-40 years that had previously been lost to follow-
up, 85% of whom had mild disease, 14% had
moderate CHD and 1% had lesions of severe
complexity.22  Of the 147 responders to the Danish
campaign seen in one main institution, 71% had
simple lesions and 29% had moderate CHD.16  Our
recall exercise differed by using hospital
appointment letters and by concentrating on only
five specific congenital lesions of moderate or
severe complexity.
Our patients’ turnout to recall was encouraging 
at 80.5%.  Response rates to recall reported in other 
studies with a known patient denominator were all 
lower: 40% response rate from repaired atrial and 
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ventricular septal defects recalled in Belgium by 
Gabriels et al 23, 47% return to clinical care among 
the patients with moderate/severe CHD contacted 
for telephone interview by Mackie et al 15 and 38% 
of patients with operated TOF accepting to be 
referred to a GUCH service after a telephone 
interview in the study by Wray et al.20  Although, at 
first glance, patient response to our exercise was 
better, it is difficult to compare considering the 
differences in congenital pathologies and means of 
contacting patients employed by different author 
groups. 
(c) Consequences of loss to follow-up
The main risk of loss to follow-up is that
patients find themselves living with residual or new 
structural lesions, arrhythmias or ventricular 
dysfunction for a protracted period of time and only 
present late with symptoms of decompensation, 
when it is either too late to get an optimal outcome 
from intervention or possibly too late to even 
contemplate one.  Indeed, cardiac symptoms 8,19 and 
arrhythmias 8 were among the commonest reported 
reasons for patients not under active follow-up to 
seek clinical assessment.  
Among patients in our cohort that returned to 
specialist care after recall, significant cardiac 
morbidity was found in 15.2%, with these patients 
needing some form of prompt intervention after 
their reassessment.  Following their nationwide 
campaign in the Netherlands, Vis et al 22 diagnosed 
previously unknown residual lesions in 16% of 
patients that accepted a new cardiology review and, 
of these, 6% were found to warrant prompt 
intervention.  Among the patients returning to care 
after the Danish recall exercise, Iversen et al 
reported moderate/severe PR in 55.6% of TOF 
patients, moderate/severe atrioventricular valve 
regurgitation in 75% of AVSDs and significant 
recoarctation in 20% of patients with repaired 
CoA.16  De Bono et al 21 found 55% of the patients 
with repaired CoA referred to their regional GUCH 
centre to require the introduction of new 
medications mainly for better management of 
arterial hypertension and 22% of patients needed 
referral for specialist investigation or invasive 
treatment following their initial assessment.  Yeung 
et al 8 made a new diagnosis of haemodynamic 
significance in 60% of their patients returning to 
cardiology care and were able to demonstrate a 
significant association between lapse of medical 
care and need for urgent cardiovascular 
intervention.  Considering the early timing of 
interventions in a proportion of patients returning to 
care in these different studies, it is reasonable to 
postulate that some, if not all, would have been put 
forward for such treatment even earlier had they not 
been lost to follow-up.  Furthermore, as Wray et al 
argue in their study on repaired TOF patients lost to 
follow-up 20, loss to follow-up could also increase 
the risk of premature cardiac-related death by 
denying patients access to procedures that could 
improve long-term outcomes if performed in a 
timely fashion. 
Limitations 
A main limitation of our study is the small 
number of patients included, which is in itself a 
result of the small Maltese population.  In our 
study, patients with mild CHD were purposefully 
excluded as we aimed to concentrate on patients 
with moderate/severe disease where a consensus on 
need for regular follow-up is well-established.  
Automatically, this precluded us from analysing 
loss to follow-up among patients with milder 
disease compared to those with more severe forms 
as done in other studies referred to earlier.  The 
authors recognise that the use of an interview or 
questionnaire for patients returning to specialist 
care would have helped shed a different light on 
reasons behind loss to follow-up so as to avoid it 
recurring in the future.  Incomplete note keeping 
made it difficult to determine the age at last visit 
prior to loss to follow-up for some of the patients 
and thus this aspect was omitted during analysis. 
Conclusions 
Patients with CHD remain prone to loss to 
specialist follow-up even in health systems with 
little perceived barriers to medical care like the one 
in place in Malta.  Loss to follow-up can delay the 
management of significant new or residual 
structural lesions, arrhythmias or ventricular 
dysfunction, which in turn can have a negative 
impact on outcomes.  Effective transfer from 
paediatric to adult care requires consistent specialist 
input from the early stages, coupled with age-
appropriate patient and family education 
highlighting the rationale for and importance of, 
long-term follow-up, even in the absence of 
symptoms.  Non-congenital cardiologists and 
physicians should be made equally aware of the 
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importance of follow-up for CHD patients and be 
provided with an easy referral route to GUCH 
services.  A formal transition process should help 
consolidate the process of patient empowerment 
18,24-25, while also identifying patients with social 
and financial issues that might be at higher risk of 
defaulting future appointments.8 
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